| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |